A-1 Acid Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:20 pm

Quick Insight

A-1 Acid Ltd, in the inorganic chemicals sector, currently trades at ₹665 with a market cap of ₹765 Cr. Despite a high P/E ratio of 210, the company's ROE stands at 7.49%, and ROCE at 10.2%. With a meager OPM of 2.22% and a net profit of ₹4 Cr, its financial health raises concerns. The strong promoter holding of 70.03% is a positive sign, but the low FII ownership at 2.90% might indicate a lack of external investor confidence. The company's high P/BV ratio of 8.29x and ICR of 8.50x suggest overvaluation and potential liquidity issues due to ₹22 Cr in borrowings. In conclusion, A-1 Acid Ltd appears to face profitability and leverage challenges despite significant promoter support.

Competitors of A-1 Acid Ltd

All Competitor Stocks of A-1 Acid Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:14 am

Below is a detailed analysis of the quarterly data for A-1 Acid Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 109.62 Cr.. The value appears strong and on an upward trend. It has increased from 74.33 Cr. (Dec 2024) to 109.62 Cr., marking an increase of 35.29 Cr..
• For Expenses, as of Mar 2025, the value is 107.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 71.50 Cr. (Dec 2024) to 107.19 Cr., marking an increase of 35.69 Cr..
• For Operating Profit, as of Mar 2025, the value is 2.43 Cr.. The value appears to be declining and may need further review. It has decreased from 2.83 Cr. (Dec 2024) to 2.43 Cr., marking a decrease of 0.40 Cr..
• For OPM %, as of Mar 2025, the value is 2.22%. The value appears to be declining and may need further review. It has decreased from 3.81% (Dec 2024) to 2.22%, marking a decrease of 1.59%.
• For Other Income, as of Mar 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Dec 2024) to 0.05 Cr., marking a decrease of 0.06 Cr..
• For Interest, as of Mar 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.68 Cr. (Dec 2024) to 0.38 Cr., marking a decrease of 0.30 Cr..
• For Depreciation, as of Mar 2025, the value is 0.92 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.90 Cr. (Dec 2024) to 0.92 Cr., marking an increase of 0.02 Cr..
• For Profit before tax, as of Mar 2025, the value is 1.18 Cr.. The value appears to be declining and may need further review. It has decreased from 1.36 Cr. (Dec 2024) to 1.18 Cr., marking a decrease of 0.18 Cr..
• For Tax %, as of Mar 2025, the value is 27.97%. The value appears to be increasing, which may not be favorable. It has increased from 26.47% (Dec 2024) to 27.97%, marking an increase of 1.50%.
• For Net Profit, as of Mar 2025, the value is 0.84 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Dec 2024) to 0.84 Cr., marking a decrease of 0.16 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.73. The value appears to be declining and may need further review. It has decreased from 0.87 (Dec 2024) to 0.73, marking a decrease of 0.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:21 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:02 pm

Below is a detailed analysis of the balance sheet data for A-1 Acid Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2024) to 38.00 Cr., marking an increase of 2.00 Cr..
• For Borrowings, as of Mar 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 11.00 Cr. (Mar 2024) to 22.00 Cr., marking an increase of 11.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 74.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 64.00 Cr. (Mar 2024) to 74.00 Cr., marking an increase of 10.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2024) to 11.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Other Assets, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 13.00 Cr..
• For Total Assets, as of Mar 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2024) to 74.00 Cr., marking an increase of 10.00 Cr..

Notably, the Reserves (38.00 Cr.) exceed the Borrowings (22.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for A-1 Acid Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
• For Diluted EPS (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
• For Cash EPS (Rs.), as of Mar 24, the value is 4.41. This value is within the healthy range. It has decreased from 6.67 (Mar 23) to 4.41, marking a decrease of 2.26.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 41.54. It has decreased from 42.09 (Mar 23) to 41.54, marking a decrease of 0.55.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 41.54. It has decreased from 42.09 (Mar 23) to 41.54, marking a decrease of 0.55.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 179.25. It has decreased from 287.48 (Mar 23) to 179.25, marking a decrease of 108.23.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 5.60. This value is within the healthy range. It has decreased from 9.27 (Mar 23) to 5.60, marking a decrease of 3.67.
• For PBIT / Share (Rs.), as of Mar 24, the value is 2.48. This value is within the healthy range. It has decreased from 5.79 (Mar 23) to 2.48, marking a decrease of 3.31.
• For PBT / Share (Rs.), as of Mar 24, the value is 1.82. This value is within the healthy range. It has decreased from 4.19 (Mar 23) to 1.82, marking a decrease of 2.37.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 1.28. This value is below the healthy minimum of 2. It has decreased from 3.19 (Mar 23) to 1.28, marking a decrease of 1.91.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 2. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
• For PBDIT Margin (%), as of Mar 24, the value is 3.12. This value is below the healthy minimum of 10. It has decreased from 3.22 (Mar 23) to 3.12, marking a decrease of 0.10.
• For PBIT Margin (%), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 10. It has decreased from 2.01 (Mar 23) to 1.38, marking a decrease of 0.63.
• For PBT Margin (%), as of Mar 24, the value is 1.01. This value is below the healthy minimum of 10. It has decreased from 1.45 (Mar 23) to 1.01, marking a decrease of 0.44.
• For Net Profit Margin (%), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 1.11 (Mar 23) to 0.71, marking a decrease of 0.40.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 8. It has decreased from 1.09 (Mar 23) to 0.53, marking a decrease of 0.56.
• For Return on Networth / Equity (%), as of Mar 24, the value is 2.29. This value is below the healthy minimum of 15. It has decreased from 7.46 (Mar 23) to 2.29, marking a decrease of 5.17.
• For Return on Capital Employeed (%), as of Mar 24, the value is 5.57. This value is below the healthy minimum of 10. It has decreased from 12.45 (Mar 23) to 5.57, marking a decrease of 6.88.
• For Return On Assets (%), as of Mar 24, the value is 1.72. This value is below the healthy minimum of 5. It has decreased from 5.33 (Mar 23) to 1.72, marking a decrease of 3.61.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.05, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.22. This value is within the healthy range. It has decreased from 0.29 (Mar 23) to 0.22, marking a decrease of 0.07.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 3.14. It has decreased from 4.48 (Mar 23) to 3.14, marking a decrease of 1.34.
• For Current Ratio (X), as of Mar 24, the value is 3.48. This value exceeds the healthy maximum of 3. It has increased from 3.20 (Mar 23) to 3.48, marking an increase of 0.28.
• For Quick Ratio (X), as of Mar 24, the value is 3.33. This value exceeds the healthy maximum of 2. It has increased from 3.11 (Mar 23) to 3.33, marking an increase of 0.22.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 8.50. This value is within the healthy range. It has increased from 5.81 (Mar 23) to 8.50, marking an increase of 2.69.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.94. This value is below the healthy minimum of 3. It has decreased from 3.00 (Mar 23) to 2.94, marking a decrease of 0.06.
• For Enterprise Value (Cr.), as of Mar 24, the value is 399.87. It has decreased from 401.40 (Mar 23) to 399.87, marking a decrease of 1.53.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.94. This value is within the healthy range. It has increased from 1.21 (Mar 23) to 1.94, marking an increase of 0.73.
• For EV / EBITDA (X), as of Mar 24, the value is 62.10. This value exceeds the healthy maximum of 15. It has increased from 37.67 (Mar 23) to 62.10, marking an increase of 24.43.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.18 (Mar 23) to 1.92, marking an increase of 0.74.
• For Price / BV (X), as of Mar 24, the value is 8.29. This value exceeds the healthy maximum of 3. It has increased from 8.07 (Mar 23) to 8.29, marking an increase of 0.22.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.18 (Mar 23) to 1.92, marking an increase of 0.74.
• For EarningsYield, as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness